Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Current Pharmaceutical Design|July 26, 2012
Structure and ligand-based design of P-glycoprotein inhibitors: a historical perspectiveAndreia Palmeira, Emilia Sousa, M Helena Vasconcelos, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 16, 2010
Compounds from wild mushrooms with antitumor potentialIsabel C F R Ferreira, Josiana A Vaz, M Helena Vasconcelos, et al.
Cytokine & Growth Factor Reviews|May 24, 2023
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistanceBárbara Polónia, Cristina P R Xavier, Joanna Kopecka, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 28, 2012
Multidrug resistance reversal effects of aminated thioxanthones and interaction with cytochrome P450 3A4Andreia Palmeira, Emília Sousa, Miguel X Fernandes, et al.
Journal of Cellular Biochemistry|November 12, 2010
EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposideRaquel T Lima, Hugo Seca, Paula Soares, et al.
Chemotherapy|May 5, 2011
Treatment of Akata EBV-positive cells with doxorubicin causes more EBV reactivation than treatment with etoposideRaquel T Lima, Hugo Seca, Susana Brás, et al.
Journal of Pharmacological Sciences|September 6, 2005
Evidence for a specific intracellular localization of an antisense oligonucleotide in k562 cellsM Helena Vasconcelos, Luis F Maia, Cristina Sousa, et al.
Chemical Biology & Drug Design|January 18, 2011
New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitorsAndreia Palmeira, Freddy Rodrigues, Emília Sousa, et al.
Toxicology and Applied Pharmacology|July 26, 2002
Metal- and tissue-dependent relationship between metallothionein mRNA and proteinM Helena Vasconcelos, Shuk-Ching Tam, John E Hesketh, et al.
Cancer Gene Therapy|March 20, 2004
Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cellsRaquel T Lima, Luís M Martins, José E Guimarães, et al.
Pageof 11